Next Science Ltd (AU:NXS) — Market Cap & Net Worth
Market Cap & Net Worth: Next Science Ltd (NXS)
Next Science Ltd (AU:NXS) has a market capitalization of $30.02 Million (AU$42.43 Million) as of May 6, 2026. Listed on the AU stock exchange, this Australia-based company holds position #23717 globally and #947 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Next Science Ltd's stock price AU$0.15 by its total outstanding shares 292625365 (292.63 Million). Analyse Next Science Ltd operating cash flow efficiency to see how efficiently the company converts income to cash.
Next Science Ltd Market Cap History: 2019 to 2026
Next Science Ltd's market capitalization history from 2019 to 2026. Data shows change from $389.26 Million to $30.02 Million (-27.89% CAGR).
Next Science Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Next Science Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.04x
Next Science Ltd's market cap is 1.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $389.26 Million | $4.11 Million | -$14.52 Million | 94.72x | N/A |
| 2020 | $258.81 Million | $3.44 Million | -$11.91 Million | 75.22x | N/A |
| 2021 | $257.78 Million | $8.95 Million | -$9.35 Million | 28.81x | N/A |
| 2022 | $141.83 Million | $11.71 Million | -$18.30 Million | 12.11x | N/A |
| 2023 | $70.40 Million | $22.18 Million | -$24.51 Million | 3.17x | N/A |
| 2024 | $23.81 Million | $22.82 Million | -$10.59 Million | 1.04x | N/A |
Competitor Companies of NXS by Market Capitalization
Companies near Next Science Ltd in the global market cap rankings as of May 6, 2026.
Key companies related to Next Science Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #498 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #524 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- Zoetis Inc (NYSE:ZTS): Ranked #534 globally with a market cap of $49.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #573 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #498 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #524 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #534 | Zoetis Inc | NYSE:ZTS | $49.60 Billion | $112.54 |
| #573 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.24 |
Next Science Ltd Historical Marketcap From 2019 to 2026
Between 2019 and today, Next Science Ltd's market cap moved from $389.26 Million to $ 30.02 Million, with a yearly change of -27.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$30.02 Million | 0.00% |
| 2025 | AU$30.02 Million | +26.09% |
| 2024 | AU$23.81 Million | -66.18% |
| 2023 | AU$70.40 Million | -50.36% |
| 2022 | AU$141.83 Million | -44.98% |
| 2021 | AU$257.78 Million | -0.40% |
| 2020 | AU$258.81 Million | -33.51% |
| 2019 | AU$389.26 Million | -- |
End of Day Market Cap According to Different Sources
On May 6th, 2026 the market cap of Next Science Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.02 Million USD |
| MoneyControl | $30.02 Million USD |
| MarketWatch | $30.02 Million USD |
| marketcap.company | $30.02 Million USD |
| Reuters | $30.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Next Science Ltd
Next Science Limited engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial wound Gel; acne gel; oral rinse; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides woun… Read more